-
Will Bioresorbable Vascular Stents Overtake Drug-Eluting Stents As The Gold Standard In CAD Treatment?
Thank you for your interest in Will Bioresorbable Vascular Stents Overtake Drug-Eluting Stents As The Gold Standard In CAD Treatment? Please fill out the form below to access your whitepaper.
-
The Rocky Road For Value-Based Orthopedic Care In The U.S.
Healthcare and legislative leaders in the U.S. have made countless efforts to move away from a supply-driven healthcare system. This is attributable, in part, to an endless number of fraud cases,...
-
DRG's Epidemiology's Global Pancreatic Cancer Forecast, 2017-2027
This live session took place on Wednesday, July 5th, 2017. Nicole Zhang presents DRG’s epidemiological forecast of all those living with pancreatic cancer worldwide in 2017 and 2027. The numbers...
-
The Politics of U.S. Healthcare - Exchanges & Insights in the Trump Era
As part of an ongoing webinar series, this live session took place on Tuesday, June 27th, 2017. Under the Trump administration, the U.S. healthcare system is facing another major overhaul. Few...
-
Insights from the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting
DRG’s oncology experts help pharma companies solve their toughest business problems in drug development, product commercialization, market access, and portfolio strategy. With 20 dedicated oncology...
-
The Evolving EU5 Reimbursement Climate for Atopic Dermatitis Therapies
This live session took place on Wednesday, June 21st, 2017. The webinar will provide a detailed picture of key stakeholders in the road to market access in the EU5. For each country, the webinar will...
-
Best practices for global physician engagement and tailoring programs by country
This live session took place on Wednesday, June 21st, 2017. In today's digital-first healthcare landscape, pharma companies and brands have an enormous opportunity to deliver value to physicians in...
-
The Politics of U.S. Healthcare - Medtech Insights in the Trump Era
As part of an ongoing webinar series, this live session took place on Tuesday, June 20th 2017. This webinar answers the questions: What has happened so far and what impact will it have on...
-
Innovative Contracting: What Europe Is Teaching the World
This live session took place on Tuesday, May 23rd, 2017. Global recession and consequent cuts in healthcare budgets have made it more difficult for innovative drugs to achieve market access, let alone...
-
CAR T-Cell Therapy: The Drive to Market
Will 2017 be the debut year for CAR T-cell therapies? Likely ‘yes’! Following a crescendo of clinical advances (and setbacks) in 2016, in the first quarter of 2017, the race to market became...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
